FDA Enforcement Class II Terminated

Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma. Catalog Number: CH2O0

Recall: Z-1424-2022 · Reported July 27, 2022

Enforcement

Recall Number
Z-1424-2022
Event ID
90522
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Randox Laboratories Ltd.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
July 27, 2022
Initiation Date
June 22, 2022
Classification Date
July 20, 2022
Termination Date
May 10, 2024
Address
55 Diamond Road, N/A, Crumlin (North), N/A, N/A, Ireland

Description

Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma. Catalog Number: CH2O0

Reason

Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.

Code Info

GTIN : 05055273201130 Lot Number: 586177 Expiry Date: 28th Jan 2024

Distribution

Nationwide Distribution - MD, OR, PR, MT, WV

Quantity

15 kits